130 related articles for article (PubMed ID: 12456315)
1. Molecular etiology of mature T-cell non-Hodgkin's lymphomas.
Evens AM; Gartenhaus RB
Front Biosci; 2003 Jan; 8():d156-75. PubMed ID: 12456315
[TBL] [Abstract][Full Text] [Related]
2. Treatment of T-cell non-Hodgkin's lymphoma.
Evens AM; Gartenhaus RB
Curr Treat Options Oncol; 2004 Aug; 5(4):289-303. PubMed ID: 15233906
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
5. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.
Ong ST; Le Beau MM
Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595
[TBL] [Abstract][Full Text] [Related]
8. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
9. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
10. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
11. SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas.
Bhansali RS; Barta SK
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):642-650. PubMed ID: 37302955
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
13. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma.
Chen CY; Yao M; Tang JL; Tsay W; Wang CC; Chou WC; Su IJ; Lee FY; Liu MC; Tien HF
Ann Oncol; 2004 Jul; 15(7):1091-6. PubMed ID: 15205204
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement of T-cell receptor delta chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders.
Kimura N; Takihara Y; Akiyoshi T; Yoshida T; Ohshima K; Kawara T; Hisano S; Kozuru M; Okumura M; Kikuchi M
Cancer Res; 1989 Aug; 49(16):4488-92. PubMed ID: 2501027
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular characterization of a hepatosplenic T-cell lymphoma: report of a novel chromosomal aberration.
Mandava S; Sonar R; Ahmad F; Yadav AK; Chheda P; Ramani M; Gupta AD; Das BR
Cancer Genet; 2011 Feb; 204(2):103-7. PubMed ID: 21504708
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T-cell lymphoma: frequency and distribution in a tertiary referral center in South India.
Burad DK; Therese MM; Nair S
Indian J Pathol Microbiol; 2012; 55(4):429-32. PubMed ID: 23455774
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
